Immorta Bio Demonstrates Dramatic Lifespan Extension in Aging Mouse Models; Research Accepted for Presentation at AAI's IMMUNOLOGY2026

Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced breakthrough preclinical results demonstrating ...
Morningstar

Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models

Scientific Longevity Company to Present New Breakthrough Data at J.P. Morgan–Affiliated Biotech Showcase 2026 MIAMI and SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity ...
BioWorld

Immorta’s dual-platform strategy doubles lifespan in aging models

Immorta Bio Inc. has reported new data demonstrating that its combination therapy of Senovax, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its ...
Morningstar

Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards

LAS VEGAS, March 3, 2026 /PRNewswire/ -- Avaí Bio, Inc. (OTCQB: AVAI) ("Avaí" or the "Company"), an emerging biotechnology company developing transformative cell-based therapies for diabetes, ...
EurekAlert!

Longevity pioneer Rejuve.Bio announced as sponsor of Aging Research & Drug Discovery Meeting (ARDD 2025), the world's largest meeting in aging research

News, 7 August 2025: Rejuve.Bio, the BioAI company pioneering a neural-symbolic AI‑driven co-scientist platform aimed at accelerating drug discovery for extending human healthspan and targeting ...
BioWorld

Insights into ‘intrinsic capacity’ could aid antiaging drug discovery

Researchers at the Buck Institute for Research on Aging have developed an epigenetic clock that could predict an individual’s intrinsic capacity score, a composite score that is a measure of healthy ...
Yahoo Finance

Immorta Bio Demonstrates Dramatic Lifespan Extension in Aging Mouse Models; Research Accepted for Presentation at AAI's IMMUNOLOGY2026

MIAMI, March 11, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced ...
EurekAlert!

Longevity pioneer Rejuve.Bio announced as sponsor of Aging Research & Drug Discovery Meeting (ARDD 2025), the world's largest meeting in aging research (IMAGE)

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...